Literature DB >> 5937251

Synthesis of nucleic acid and protein in L cells infected with the agent of meningopneumonitis.

E M Schechter.   

Abstract

Schechter, Esther M. (The University of Chicago, Chicago, Ill.). Synthesis of nucleic acid and protein in L cells infected with the agent of meningopneumonitis. J. Bacteriol. 91:2069-2080. 1966.-Synthesis of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and protein in uninfected L cells and in L cells infected with the meningopneumonitis agent was compared by measuring rates of incorporation of H(3)-cytidine and C(14)-lysine into nuclear, cytoplasmic, and agent fractions in successive 5-hr periods during the meningopneumonitis growth cycle. Synthesis of meningopneumonitis DNA, RNA, and protein was first clearly evident in the labeling period 15 to 20 hr after infection, soon after initiation of agent multiplication. The rates of synthesis of agent DNA, RNA, and protein increased logarithmically for a brief period and then declined. However, rates of isotope incorporation into all three meningopneumonitis macromolecules were sustained at near maximal values throughout the remainder of the meningopneumonitis growth cycle. These data are most readily interpreted in terms of multiplication of the meningopneumonitis agent by binary fission. The L cell response to infection was a decreased rate of DNA and RNA synthesis and an accelerated rate of cell death. Host protein synthesis was unaffected. The inhibition of nucleic acid synthesis in infected L cells probably involved competition between host and parasite for nucleic acid precursors. Different sublines of L cells varied greatly in the degree to which their nucleic acid-synthesizing mechanisms were damaged by infection. The cytoplasm of infected L cells contained newly synthesized DNA and RNA that could not be accounted for as intact meningopneumonitis cells. This nucleic acid probably arose from disintegration of the fragile intracellular forms of the meningopneumonitis agent.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5937251      PMCID: PMC316164          DOI: 10.1128/jb.91.5.2069-2080.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  RNA SYNTHESIS IN CELLS INFECTED WITH THE MENINGOPNEUMONITIS AGENT.

Authors:  A TAMURA; M IWANAGA
Journal:  J Mol Biol       Date:  1965-01       Impact factor: 5.469

3.  POPULATION DYNAMICS AND DEOXYRIBONUCLEIC ACID SYNTHESIS IN HELA CELLS INFECTED WITH AN ORNITHOSIS AGENT.

Authors:  T T CROCKER; S R PELC; B I NIELSEN; J M EASTWOOD; J BANKS
Journal:  J Infect Dis       Date:  1965-04       Impact factor: 5.226

4.  Cytochemical studies with psittacosis virus by fluorescence microscopy.

Authors:  T J STARR; M POLLARD; Y TANAMI; R W MOORE
Journal:  Tex Rep Biol Med       Date:  1960

5.  Replication pattern of psittacosis virus in a tissue culture system.

Authors:  Y TANAMI; M POLLARD; T J STARR
Journal:  Virology       Date:  1961-09       Impact factor: 3.616

6.  The submerged culture of mammalian cells; the spinner culture.

Authors:  W F McLIMANS; E V DAVIS; F L GLOVER; G W RAKE
Journal:  J Immunol       Date:  1957-11       Impact factor: 5.422

7.  Estimation of nucleic acids.

Authors:  E VOLKIN; W E COHN
Journal:  Methods Biochem Anal       Date:  1954

8.  A comparative study of the growth cycles of different members of the psittacosis group in different host cells.

Authors:  J LITWIN; J E OFFICER; A BROWN; J W MOULDER
Journal:  J Infect Dis       Date:  1961 Nov-Dec       Impact factor: 5.226

9.  Cytochemistry of trachoma virus replication in tissue cultures.

Authors:  M POLLARD; Y TANAMI
Journal:  Ann N Y Acad Sci       Date:  1962-03-05       Impact factor: 5.691

10.  ENZYMES OF GLUCOSE CATABOLISM IN A MEMBER OF THE PSITTACOSIS GROUP.

Authors:  J W MOULDER; D L GRISSO; R R BRUBAKER
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

View more
  24 in total

1.  Ultrastructural cytochemical evidence for the activation of lysosomes in the cytocidal effect of Chlamydia psittaci.

Authors:  W J Todd; J Storz
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Inhibition of Deoxyribonucleic Acid Synthesis in Synchronized Populations of L Cells Infected with Chlamydia psittaci.

Authors:  I I Tribby; J W Moulder
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

4.  Characterization and identification of early proteins in Chlamydia trachomatis serovar L2 by two-dimensional gel electrophoresis.

Authors:  A G Lundemose; S Birkelund; P M Larsen; S J Fey; G Christiansen
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 5.  The chlamydia: molecular biology of procaryotic obligate parasites of eucaryocytes.

Authors:  Y Becker
Journal:  Microbiol Rev       Date:  1978-06

6.  Growth of Chlamydia psittaci strain meningopneumonitis in mouse L cells cultivated in a defined medium in spinner cultures.

Authors:  S J Morrison; H M Jenkin
Journal:  In Vitro       Date:  1972 Sep-Oct

7.  Inhibition of thymidine kinase activity and deoxyribonucleic acid synthesis in L cells infected with the meningopneumonitis agent.

Authors:  H S Lin
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

8.  Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells).

Authors:  G I Byrne
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Biosynthesis of arginine in L cells infected with chlamydiae.

Authors:  M W Treuhaft; J W Moulder
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

10.  Stability of the nucleic acids of L cells after infection with the meningopneumonitis agent.

Authors:  H S Lin
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.